Cancer Cell
Volume 12, Issue 2, 14 August 2007, Pages 131-144
Journal home page for Cancer Cell

Article
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

https://doi.org/10.1016/j.ccr.2007.07.003Get rights and content
Under an Elsevier user license
open archive

Summary

Activation of NF-κB has been noted in many tumor types, however only rarely has this been linked to an underlying genetic mutation. An integrated analysis of high-density oligonucleotide array CGH and gene expression profiling data from 155 multiple myeloma samples identified a promiscuous array of abnormalities contributing to the dysregulation of NF-κB in approximately 20% of patients. We report mutations in ten genes causing the inactivation of TRAF2, TRAF3, CYLD, cIAP1/cIAP2 and activation of NFKB1, NFKB2, CD40, LTBR, TACI, and NIK that result primarily in constitutive activation of the noncanonical NF-κB pathway, with the single most common abnormality being inactivation of TRAF3. These results highlight the critical importance of the NF-κB pathway in the pathogenesis of multiple myeloma.

SIGNALING
CELLCYCLE

Cited by (0)

7

These authors contributed equally to this work.